Press Releases
Recro Pharma Announces Dosing of First Patient in Phase II REC-14-013 Clinical Trial of Dex-IN for Treatment of Acute Pain on Day 1 Following Surgery
Recro Pharma to Present at the 2014 Aegis Healthcare & Technology Conference
Recro Pharma Provides Clinical Strategy Update Following Interim Analysis for Phase IIb Clinical Trial of Dex-IN
Recro Pharma Reports Second Quarter 2014 Financial Results
Recro Pharma Added to Russell Microcap(R) Index
Recro Pharma Announces Dosing of First Patient in Phase IIb Clinical Trial of Dex-IN for Treatment of Acute Pain Following Surgery
Recro Pharma Reports First Quarter 2014 Financial Results
Recro Pharma Announces New Board Members
Recro Pharma Announces Closing of Initial Public Offering
